Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.
Myotonic dystrophy type 1 (DM1) is caused by an unstable CTG repeat expansion in the 3'UTR of the DM protein kinase (DMPK) gene. DMPK transcripts carrying CUG expansions form nuclear foci and affect splicing regulation of various RNA transcripts. Furthermore, bidirectional transcription over th...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC3510028?pdf=render |
id |
doaj-46d7bd16ec6346da904e248c561430b5 |
---|---|
record_format |
Article |
spelling |
doaj-46d7bd16ec6346da904e248c561430b52020-11-24T22:04:57ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042012-01-01811e100304310.1371/journal.pgen.1003043Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.Aline HuguetFadia MedjaAnnie NicoleAlban VignaudCéline Guiraud-DoganArnaud FerryValérie DecostreJean-Yves HogrelFriedrich MetzgerAndreas HoeflichMartin BaraibarMário Gomes-PereiraJack PuymiratGuillaume BassezDenis FurlingArnold MunnichGeneviève GourdonMyotonic dystrophy type 1 (DM1) is caused by an unstable CTG repeat expansion in the 3'UTR of the DM protein kinase (DMPK) gene. DMPK transcripts carrying CUG expansions form nuclear foci and affect splicing regulation of various RNA transcripts. Furthermore, bidirectional transcription over the DMPK gene and non-conventional RNA translation of repeated transcripts have been described in DM1. It is clear now that this disease may involve multiple pathogenic pathways including changes in gene expression, RNA stability and splicing regulation, protein translation, and micro-RNA metabolism. We previously generated transgenic mice with 45-kb of the DM1 locus and >300 CTG repeats (DM300 mice). After successive breeding and a high level of CTG repeat instability, we obtained transgenic mice carrying >1,000 CTG (DMSXL mice). Here we described for the first time the expression pattern of the DMPK sense transcripts in DMSXL and human tissues. Interestingly, we also demonstrate that DMPK antisense transcripts are expressed in various DMSXL and human tissues, and that both sense and antisense transcripts accumulate in independent nuclear foci that do not co-localize together. Molecular features of DM1-associated RNA toxicity in DMSXL mice (such as foci accumulation and mild missplicing), were associated with high mortality, growth retardation, and muscle defects (abnormal histopathology, reduced muscle strength, and lower motor performances). We have found that lower levels of IGFBP-3 may contribute to DMSXL growth retardation, while increased proteasome activity may affect muscle function. These data demonstrate that the human DM1 locus carrying very large expansions induced a variety of molecular and physiological defects in transgenic mice, reflecting DM1 to a certain extent. As a result, DMSXL mice provide an animal tool to decipher various aspects of the disease mechanisms. In addition, these mice can be used to test the preclinical impact of systemic therapeutic strategies on molecular and physiological phenotypes.http://europepmc.org/articles/PMC3510028?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Aline Huguet Fadia Medja Annie Nicole Alban Vignaud Céline Guiraud-Dogan Arnaud Ferry Valérie Decostre Jean-Yves Hogrel Friedrich Metzger Andreas Hoeflich Martin Baraibar Mário Gomes-Pereira Jack Puymirat Guillaume Bassez Denis Furling Arnold Munnich Geneviève Gourdon |
spellingShingle |
Aline Huguet Fadia Medja Annie Nicole Alban Vignaud Céline Guiraud-Dogan Arnaud Ferry Valérie Decostre Jean-Yves Hogrel Friedrich Metzger Andreas Hoeflich Martin Baraibar Mário Gomes-Pereira Jack Puymirat Guillaume Bassez Denis Furling Arnold Munnich Geneviève Gourdon Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus. PLoS Genetics |
author_facet |
Aline Huguet Fadia Medja Annie Nicole Alban Vignaud Céline Guiraud-Dogan Arnaud Ferry Valérie Decostre Jean-Yves Hogrel Friedrich Metzger Andreas Hoeflich Martin Baraibar Mário Gomes-Pereira Jack Puymirat Guillaume Bassez Denis Furling Arnold Munnich Geneviève Gourdon |
author_sort |
Aline Huguet |
title |
Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus. |
title_short |
Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus. |
title_full |
Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus. |
title_fullStr |
Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus. |
title_full_unstemmed |
Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus. |
title_sort |
molecular, physiological, and motor performance defects in dmsxl mice carrying >1,000 ctg repeats from the human dm1 locus. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Genetics |
issn |
1553-7390 1553-7404 |
publishDate |
2012-01-01 |
description |
Myotonic dystrophy type 1 (DM1) is caused by an unstable CTG repeat expansion in the 3'UTR of the DM protein kinase (DMPK) gene. DMPK transcripts carrying CUG expansions form nuclear foci and affect splicing regulation of various RNA transcripts. Furthermore, bidirectional transcription over the DMPK gene and non-conventional RNA translation of repeated transcripts have been described in DM1. It is clear now that this disease may involve multiple pathogenic pathways including changes in gene expression, RNA stability and splicing regulation, protein translation, and micro-RNA metabolism. We previously generated transgenic mice with 45-kb of the DM1 locus and >300 CTG repeats (DM300 mice). After successive breeding and a high level of CTG repeat instability, we obtained transgenic mice carrying >1,000 CTG (DMSXL mice). Here we described for the first time the expression pattern of the DMPK sense transcripts in DMSXL and human tissues. Interestingly, we also demonstrate that DMPK antisense transcripts are expressed in various DMSXL and human tissues, and that both sense and antisense transcripts accumulate in independent nuclear foci that do not co-localize together. Molecular features of DM1-associated RNA toxicity in DMSXL mice (such as foci accumulation and mild missplicing), were associated with high mortality, growth retardation, and muscle defects (abnormal histopathology, reduced muscle strength, and lower motor performances). We have found that lower levels of IGFBP-3 may contribute to DMSXL growth retardation, while increased proteasome activity may affect muscle function. These data demonstrate that the human DM1 locus carrying very large expansions induced a variety of molecular and physiological defects in transgenic mice, reflecting DM1 to a certain extent. As a result, DMSXL mice provide an animal tool to decipher various aspects of the disease mechanisms. In addition, these mice can be used to test the preclinical impact of systemic therapeutic strategies on molecular and physiological phenotypes. |
url |
http://europepmc.org/articles/PMC3510028?pdf=render |
work_keys_str_mv |
AT alinehuguet molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT fadiamedja molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT annienicole molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT albanvignaud molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT celineguirauddogan molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT arnaudferry molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT valeriedecostre molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT jeanyveshogrel molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT friedrichmetzger molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT andreashoeflich molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT martinbaraibar molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT mariogomespereira molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT jackpuymirat molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT guillaumebassez molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT denisfurling molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT arnoldmunnich molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus AT genevievegourdon molecularphysiologicalandmotorperformancedefectsindmsxlmicecarrying1000ctgrepeatsfromthehumandm1locus |
_version_ |
1725828042562994176 |